Form 4: ADC Therapeutics Chief Legal Officer Sells Shares to Cover Tax Obligations

Peter Graham, Chief Legal Officer of ADC Therapeutics, sold 41,458 common shares to cover tax obligations related to vesting restricted share units.

Summary

• Peter Graham, the Chief Legal Officer of ADC Therapeutics, sold 41,458 common shares on December 6, 2024.
• The shares were sold at a price of $3.13 per share.
• This transaction was to cover tax withholding obligations related to the vesting of previously granted restricted share units.
• Following the transaction, Mr. Graham directly owns 188,542 common shares.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, not indicative of positive or negative sentiment towards the company's performance.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Sales of shares by executives to cover tax obligations are a common practice across the industry.
• Many companies use restricted stock units as part of their compensation packages, leading to similar transactions when these units vest.
• The sale of shares by an executive is not unusual and does not necessarily indicate a negative outlook for the company.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.

Key Dates

Keywords

SEC Form 4, insider trading, share sale, ADC Therapeutics, ADCT, Peter Graham, Chief Legal Officer, tax obligations, restricted share units